Communication of gut microbiota and brain via immune and neuroendocrine signaling

The gastrointestinal tract of the human is inhabited by about 5 × 1013 bacteria (of about 1,000 species) as well as archaea, fungi, and viruses. Gut microbiota is known to influence the host organism, but the host may also affect the functioning of the microbiota. This bidirectional cooperation occurs in three main inter-organ signaling: immune, neural, and endocrine. Immune communication relies mostly on the cytokines released by the immune cells into circulation. Also, pathogen-associated or damage-associated molecular patterns (PAMPs or DAMPs) may enter circulation and affect the functioning of the internal organs and gut microbiota. Neural communication relies mostly on the direct anatomical connections made by the vagus nerve, or indirect connections via the enteric nervous system. The third pathway, endocrine communication, is the broadest one and includes the hypothalamic-pituitary-adrenal axis. This review focuses on presenting the latest data on the role of the gut microbiota in inter-organ communication with particular emphasis on the role of neurotransmitters (catecholamines, serotonin, gamma-aminobutyric acid), intestinal peptides (cholecystokinin, peptide YY, and glucagon-like peptide 1), and bacterial metabolites (short-chain fatty acids).

[1]  Nazim Uddin Emon,et al.  Role of Gut Microbiome in Autism Spectrum Disorder and Its Therapeutic Regulation , 2022, Frontiers in Cellular and Infection Microbiology.

[2]  D. Reed,et al.  Excitation of Vagal Afferent Neurons by Fecal Supernatant from Inflammatory Bowel Disease Patients , 2022, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  Henry C. Lin,et al.  Norepinephrine induces growth of Desulfovibrio vulgaris in an iron dependent manner. , 2022, Anaerobe.

[4]  H. Peng,et al.  Intestinal Dopamine Receptor D2 is Required for Neuroprotection Against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Dopaminergic Neurodegeneration , 2022, Neuroscience Bulletin.

[5]  J. Riddell,et al.  Chemogenetics defines a short-chain fatty acid receptor gut–brain axis , 2022, eLife.

[6]  G. Ricevuti,et al.  The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment , 2022, Nutrients.

[7]  A. Starkweather,et al.  Associations of neurotransmitters and the gut microbiome with emotional distress in mixed type of irritable bowel syndrome , 2022, Scientific Reports.

[8]  Parichehr Amiri,et al.  Role of Butyrate, a Gut Microbiota Derived Metabolite, in Cardiovascular Diseases: A comprehensive narrative review , 2022, Frontiers in Pharmacology.

[9]  A. Cudnoch-Jędrzejewska,et al.  New Peptides as Potential Players in the Crosstalk Between the Brain and Obesity, Metabolic and Cardiovascular Diseases , 2021, Frontiers in Physiology.

[10]  S. Choi,et al.  Cognitive function improvement after fecal microbiota transplantation in Alzheimer’s dementia patient: a case report , 2021, Current medical research and opinion.

[11]  S. Rosshart,et al.  The Microbiota-Gut-Brain Axis in Health and Disease and Its Implications for Translational Research , 2021, Frontiers in Cellular Neuroscience.

[12]  P. Forsythe,et al.  Loss of vagal integrity disrupts immune components of the microbiota-gut-brain axis and inhibits the effect of Lactobacillus rhamnosus on behavior and the corticosterone stress response , 2021, Neuropharmacology.

[13]  Sun-Young Chang,et al.  Gut-Brain Connection: Microbiome, Gut Barrier, and Environmental Sensors , 2021, Immune network.

[14]  W. Lukiw,et al.  Gastrointestinal Tract Microbiome-Derived Pro-inflammatory Neurotoxins in Alzheimer’s Disease , 2021, Journal of aging science.

[15]  Ning Zhang,et al.  Links Between Gut Dysbiosis and Neurotransmitter Disturbance in Chronic Restraint Stress-Induced Depressive Behaviours: the Role of Inflammation , 2021, Inflammation.

[16]  A. Cudnoch-Jędrzejewska,et al.  The Influence of Gut Microbiota on the Cardiovascular System Under Conditions of Obesity and Chronic Stress , 2021, Current Hypertension Reports.

[17]  K. Chaudhuri,et al.  Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation , 2021, Journal of Neurology.

[18]  W. Agace,et al.  Human gut-associated lymphoid tissues (GALT); diversity, structure, and function , 2021, Mucosal Immunology.

[19]  P. Brennan,et al.  Permeability of the blood brain barrier after traumatic brain injury: radiological considerations. , 2021, Journal of neurotrauma.

[20]  Z. Rahman,et al.  Crosstalk between gut microbiome and immunology in the management of ischemic brain injury , 2021, Journal of Neuroimmunology.

[21]  F. Asghar,et al.  TGF-β1-overexpressing mesenchymal stem cells reciprocally regulate Th17/Treg cells by regulating the expression of IFN-γ , 2021, Open life sciences.

[22]  Yong Jiang,et al.  Gut microbiota-brain interaction: An emerging immunotherapy for traumatic brain injury , 2020, Experimental Neurology.

[23]  K. Tsamis,et al.  The role of the gut-brain axis in depression: endocrine, neural, and immune pathways , 2020, Hormones.

[24]  Anthony M. Haag,et al.  Human-Derived Bifidobacterium dentium Modulates the Mammalian Serotonergic System and Gut–Brain Axis , 2020, Cellular and molecular gastroenterology and hepatology.

[25]  Liping Liu,et al.  Gut microbiota modulates stress-induced hypertension through the HPA axis , 2020, Brain Research Bulletin.

[26]  S. Hazan Rapid improvement in Alzheimer’s disease symptoms following fecal microbiota transplantation: a case report , 2020, The Journal of international medical research.

[27]  Asha,et al.  Gut–organ axis: a microbial outreach and networking , 2020, Letters in applied microbiology.

[28]  R. P. Ross,et al.  Glucagon-Like Peptide-1 Secreting L-Cells Coupled to Sensory Nerves Translate Microbial Signals to the Host Rat Nervous System , 2020, Frontiers in Cellular Neuroscience.

[29]  B. Misiak,et al.  The HPA axis dysregulation in severe mental illness: Can we shift the blame to gut microbiota? , 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[30]  C. Martyniuk,et al.  Regulation of endocrine systems by the microbiome: Perspectives from comparative animal models. , 2020, General and comparative endocrinology.

[31]  R. Frozza,et al.  The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication , 2020, Frontiers in Endocrinology.

[32]  O. Koren,et al.  The microbiota and the hypothalamus-pituitary-adrenocortical (HPA) axis, implications for anxiety and stress disorders , 2020, Current Opinion in Neurobiology.

[33]  G. Lal,et al.  CCR9 signaling in dendritic cells drives the differentiation of Foxp3+ Tregs and suppresses the allergic IgE response in the gut , 2019, European journal of immunology.

[34]  T. Hudcovic,et al.  Interactions Between Gut Microbiota and Acute Restraint Stress in Peripheral Structures of the Hypothalamic–Pituitary–Adrenal Axis and the Intestine of Male Mice , 2019, Front. Immunol..

[35]  Kieran Rea,et al.  The Microbiota-Gut-Brain Axis. , 2019, Physiological reviews.

[36]  S. Kennedy,et al.  Gut microbial metabolites in depression: understanding the biochemical mechanisms , 2019, Microbial cell.

[37]  Y. Lee,et al.  The Role of Gut Microbiota in Intestinal Inflammation with Respect to Diet and Extrinsic Stressors , 2019, Microorganisms.

[38]  Antoniya A. Aleksandrova,et al.  Intestinal serotonin and fluoxetine exposure modulate bacterial colonization in the gut , 2019, Nature Microbiology.

[39]  Mingmei Zhou,et al.  Metabolomic signatures and microbial community profiling of depressive rat model induced by adrenocorticotrophic hormone , 2019, Journal of Translational Medicine.

[40]  R. Knight,et al.  Role of the microbiome in human development , 2019, Gut.

[41]  C. Glass,et al.  Microbiome–microglia connections via the gut–brain axis , 2018, The Journal of experimental medicine.

[42]  M. Raffatellu,et al.  G.I. pros: Antimicrobial defense in the gastrointestinal tract. , 2018, Seminars in cell & developmental biology.

[43]  X. Xiong,et al.  Bidirectional gut-brain-microbiota axis as a potential link between inflammatory bowel disease and ischemic stroke , 2018, Journal of Neuroinflammation.

[44]  Bingren Hu,et al.  Brain–gut axis after stroke , 2018, Brain circulation.

[45]  L. Oudenhove,et al.  The gut–brain axis in health neuroscience: implications for functional gastrointestinal disorders and appetite regulation , 2018, Annals of the New York Academy of Sciences.

[46]  T. Dinan,et al.  Short‐chain fatty acids: microbial metabolites that alleviate stress‐induced brain–gut axis alterations , 2018, The Journal of physiology.

[47]  M. Salami,et al.  Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial , 2018, Front. Neurol..

[48]  K. Kasarełło,et al.  Common Genetic Variants Link the Abnormalities in the Gut-Brain Axis in Prematurity and Autism , 2018, The Cerebellum.

[49]  S. Lal,et al.  The Human Gut Microbiome – A Potential Controller of Wellness and Disease , 2018, Front. Microbiol..

[50]  Philip Strandwitz Neurotransmitter modulation by the gut microbiota , 2018, Brain Research.

[51]  E. Whiteside,et al.  The Gut-Brain Axis, the Human Gut Microbiota and Their Integration in the Development of Obesity , 2018, Front. Physiol..

[52]  E. Hsiao,et al.  Linking the Gut Microbiota to a Brain Neurotransmitter , 2018, Trends in Neurosciences.

[53]  M. Kimmel,et al.  Emerging literature in the Microbiota-Brain Axis and Perinatal Mood and Anxiety Disorders , 2018, Psychoneuroendocrinology.

[54]  C. Elson,et al.  Adaptive immune education by gut microbiota antigens , 2018, Immunology.

[55]  Deepti Singh,et al.  Molecular dynamics simulation studies suggests unconventional roles of non-secretary laccases from enteropathogenic gut bacteria and Cryptococcus neoformans serotype D , 2018, Comput. Biol. Chem..

[56]  Bruno Bonaz,et al.  The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis , 2018, Front. Neurosci..

[57]  Defa Li,et al.  Butyrate: A Double-Edged Sword for Health? , 2018, Advances in nutrition.

[58]  Sterling C. Johnson,et al.  Gut microbiome alterations in Alzheimer’s disease , 2017, Scientific Reports.

[59]  E. Quigley Microbiota-Brain-Gut Axis and Neurodegenerative Diseases , 2017, Current Neurology and Neuroscience Reports.

[60]  A. Lerner,et al.  The Gut Microbiome Feelings of the Brain: A Perspective for Non-Microbiologists , 2017, Microorganisms.

[61]  C. Weerth Do bacteria shape our development? Crosstalk between intestinal microbiota and HPA axis , 2017, Neuroscience & Biobehavioral Reviews.

[62]  A. Visekruna,et al.  Functional heterogeneity of gut-resident regulatory T cells , 2017, Clinical & translational immunology.

[63]  J. Ridlon,et al.  Glucocorticoids and gut bacteria: “The GALF Hypothesis” in the metagenomic era , 2017, Steroids.

[64]  David Julius,et al.  Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways , 2017, Cell.

[65]  S. Vermeire,et al.  The intestinal barrier: a fundamental role in health and disease , 2017, Expert review of gastroenterology & hepatology.

[66]  N. Juge,et al.  Introduction to the human gut microbiota , 2017, The Biochemical journal.

[67]  Wan-Uk Kim,et al.  Microbiota in T-cell homeostasis and inflammatory diseases , 2017, Experimental &Molecular Medicine.

[68]  John F. Cryan,et al.  Stress & the gut-brain axis: Regulation by the microbiome , 2017, Neurobiology of Stress.

[69]  T. Borody,et al.  Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study , 2017, Microbiome.

[70]  H. Forssberg,et al.  The bacterial peptidoglycan-sensing molecule Pglyrp2 modulates brain development and behavior , 2016, Molecular Psychiatry.

[71]  H. Weiner,et al.  Microbiota Signaling Pathways that Influence Neurologic Disease , 2018, Neurotherapeutics.

[72]  B. Bonaz,et al.  The Place of Stress and Emotions in the Irritable Bowel Syndrome. , 2017, Vitamins and hormones.

[73]  T. Dinan,et al.  Microbes, Immunity, and Behavior: Psychoneuroimmunology Meets the Microbiome , 2017, Neuropsychopharmacology.

[74]  T. Arumugam,et al.  HDAC Inhibitor Sodium Butyrate-Mediated Epigenetic Regulation Enhances Neuroprotective Function of Microglia During Ischemic Stroke , 2017, Molecular Neurobiology.

[75]  M. Salami,et al.  Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial , 2016, Front. Aging Neurosci..

[76]  V. Pachnis,et al.  The Effect of Microbiota and the Immune System on the Development and Organization of the Enteric Nervous System , 2016, Gastroenterology.

[77]  Yu-ping Wang,et al.  Gut Microbiota-brain Axis , 2016, Chinese medical journal.

[78]  T. Dinan,et al.  The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis? , 2016, Neurochemistry International.

[79]  F. Bäckhed,et al.  Signals from the gut microbiota to distant organs in physiology and disease , 2016, Nature Medicine.

[80]  R. Ratan,et al.  Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health? , 2016, Neuroscience Letters.

[81]  J. Herman,et al.  Regulation of the Hypothalamic-Pituitary-Adrenocortical Stress Response. , 2016, Comprehensive Physiology.

[82]  T. Dinan,et al.  Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome , 2016, CNS neuroscience & therapeutics.

[83]  T. Defrance,et al.  Plasmacytoid dendritic cells are dispensable for noninfectious intestinal IgA responses in vivo , 2016, European journal of immunology.

[84]  C. Mancini,et al.  Eubiosis and dysbiosis: the two sides of the microbiota. , 2016, The new microbiologica.

[85]  E. Mingomataj,et al.  Regulator Versus Effector Paradigm: Interleukin-10 as Indicator of the Switching Response , 2016, Clinical Reviews in Allergy & Immunology.

[86]  F. Duca,et al.  Regulation of energy balance by a gut–brain axis and involvement of the gut microbiota , 2016, Cellular and Molecular Life Sciences.

[87]  G. Cresci,et al.  Gut Microbiome: What We Do and Don't Know. , 2015, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[88]  M. Carabotti,et al.  The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems , 2015, Annals of gastroenterology.

[89]  A. El-Ansary,et al.  The neurotoxic effects of ampicillin-associated gut bacterial imbalances compared to those of orally administered propionic acid in the etiology of persistent autistic features in rat pups: effects of various dietary regimens , 2015, Gut Pathogens.

[90]  Lai Guan Ng,et al.  The gut microbiota influences blood-brain barrier permeability in mice , 2014, Science Translational Medicine.

[91]  D. Macfabe,et al.  Enteric Bacterial Metabolites Propionic and Butyric Acid Modulate Gene Expression, Including CREB-Dependent Catecholaminergic Neurotransmission, in PC12 Cells - Possible Relevance to Autism Spectrum Disorders , 2014, PloS one.

[92]  R. Knight,et al.  Individual diet has sex-dependent effects on vertebrate gut microbiota , 2014, Nature Communications.

[93]  V. Barrios,et al.  Peptides and Food Intake , 2014, Front. Endocrinol..

[94]  Peter Holzer,et al.  Neuropeptides and the microbiota-gut-brain axis. , 2014, Advances in experimental medicine and biology.

[95]  M. Horowitz,et al.  Gut motility and enteroendocrine secretion. , 2013, Current opinion in pharmacology.

[96]  G. Boeckxstaens,et al.  Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism , 2013, Gut.

[97]  J. Hoffman,et al.  Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets , 2013, Nature Reviews Gastroenterology &Hepatology.

[98]  F. Zhang,et al.  Adoptive regulatory T‐cell therapy protects against cerebral ischemia , 2013, Annals of neurology.

[99]  J. Bienenstock,et al.  Psychoactive bacteria Lactobacillus rhamnosus (JB-1) elicits rapid frequency facilitation in vagal afferents. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[100]  K. Kelley,et al.  Immune–neural connections: how the immune system’s response to infectious agents influences behavior , 2013, Journal of Experimental Biology.

[101]  A. Macpherson,et al.  Interactions Between the Microbiota and the Immune System , 2012, Science.

[102]  J. Nicholson,et al.  Host-Gut Microbiota Metabolic Interactions , 2012, Science.

[103]  Patrice D Cani,et al.  Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity , 2012, Gut microbes.

[104]  M. Zarepour,et al.  Innate host responses to enteric bacterial pathogens: a balancing act between resistance and tolerance , 2012, Cellular microbiology.

[105]  J. Malagelada,et al.  Chronic psychosocial stress induces reversible mitochondrial damage and corticotropin-releasing factor receptor type-1 upregulation in the rat intestine and IBS-like gut dysfunction , 2012, Psychoneuroendocrinology.

[106]  Agata Korecka,et al.  The gut microbiome: scourge, sentinel or spectator? , 2012, Journal of oral microbiology.

[107]  John F. Cryan,et al.  Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve , 2011, Proceedings of the National Academy of Sciences.

[108]  C. Hsieh,et al.  Peripheral education of the immune system by colonic commensal microbiota , 2011, Nature.

[109]  B. Corfe,et al.  Classification and functions of enteroendocrine cells of the lower gastrointestinal tract , 2011, International journal of experimental pathology.

[110]  T. Powley,et al.  Vagal afferent innervation of the proximal gastrointestinal tract mucosa: Chemoreceptor and mechanoreceptor architecture , 2011, The Journal of comparative neurology.

[111]  E. Halperin,et al.  Genotype Is a Stronger Determinant than Sex of the Mouse Gut Microbiota , 2011, Microbial Ecology.

[112]  L. Desbonnet,et al.  Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression , 2010, Neuroscience.

[113]  W. Shaw Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia , 2010, Nutritional neuroscience.

[114]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[115]  H. Raybould Gut chemosensing: Interactions between gut endocrine cells and visceral afferents , 2010, Autonomic Neuroscience.

[116]  T. Iwaki,et al.  Pivotal role of cerebral interleukin-17–producing γδT cells in the delayed phase of ischemic brain injury , 2009, Nature Medicine.

[117]  C. Sommer,et al.  Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke , 2009, Nature Medicine.

[118]  F. Powrie,et al.  CD103+ GALT DCs promote Foxp3+ regulatory T cells , 2008, Mucosal Immunology.

[119]  S. Daya,et al.  Acyclovir inhibits rat liver tryptophan-2,3-dioxygenase and induces a concomitant rise in brain serotonin and 5-hydroxyindole acetic acid levels , 2008, Metabolic Brain Disease.

[120]  P. Hellström,et al.  Appetite signaling: From gut peptides and enteric nerves to brain , 2007, Physiology & Behavior.

[121]  Eric Gouaux,et al.  Antidepressant binding site in a bacterial homologue of neurotransmitter transporters , 2007, Nature.

[122]  V. Théodorou,et al.  Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats. , 2007, The Journal of nutrition.

[123]  T. Powley,et al.  Vagal innervation of intestines: afferent pathways mapped with new en bloc horseradish peroxidase adaptation , 2007, Cell and Tissue Research.

[124]  G. MacQueen,et al.  Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation , 2007, Gut.

[125]  K. Nagai,et al.  Effects of intraduodenal injection of Lactobacillus johnsonii La1 on renal sympathetic nerve activity and blood pressure in urethane-anesthetized rats , 2005, Neuroscience Letters.

[126]  T. Matsuda,et al.  Novel pathway for LPS-induced afferent vagus nerve activation: Possible role of nodose ganglion , 2005, Autonomic Neuroscience.

[127]  William A Banks,et al.  Blood-brain barrier transport of cytokines: a mechanism for neuropathology. , 2005, Current pharmaceutical design.

[128]  S. Woods,et al.  Gastrointestinal hormones and food intake. , 2005, Gastroenterology.

[129]  A. Grace,et al.  Corticotropin-Releasing Hormone Directly Activates Noradrenergic Neurons of the Locus Ceruleus Recorded In Vitro , 2004, The Journal of Neuroscience.

[130]  Y. Chida,et al.  Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice , 2004, The Journal of physiology.

[131]  D. Fuchs,et al.  Interferon-γ-Induced Conversion of Tryptophan: Immunologic and Neuropsychiatric Aspects , 2003 .

[132]  H. Weiner,et al.  Oral tolerance , 2003, Immunologic research.

[133]  D. Thompson,et al.  Vagal afferent responses to fatty acids of different chain length in the rat. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[134]  Y. Li,et al.  Serotonin released from intestinal enterochromaffin cells mediates luminal non-cholecystokinin-stimulated pancreatic secretion in rats. , 2000, Gastroenterology.

[135]  J. Deuchars,et al.  Properties of solitary tract neurons receiving inputs from the sub-diaphragmatic vagus nerve , 1999, Neuroscience.

[136]  A. Turnbull,et al.  Regulation of the HPA Axis by Cytokines , 1995, Brain, Behavior, and Immunity.

[137]  M. Lyte,et al.  Catecholamine induced growth of gram negative bacteria. , 1992, Life sciences.